Abbott Laboratories Gross Margin 2010-2025 | ABT

Current and historical gross margin for Abbott Laboratories (ABT) over the last 10 years. The current gross profit margin for Abbott Laboratories as of March 31, 2025 is %.
Abbott Laboratories Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $42.34B $23.63B 55.81%
2024-12-31 $41.95B $23.24B 55.41%
2024-09-30 $41.22B $22.90B 55.55%
2024-06-30 $40.73B $22.50B 55.24%
2024-03-31 $40.33B $22.22B 55.10%
2023-12-31 $40.11B $22.13B 55.18%
2023-09-30 $39.96B $21.95B 54.92%
2023-06-30 $40.23B $22.19B 55.16%
2023-03-31 $41.51B $23.02B 55.46%
2022-12-31 $43.65B $24.51B 56.15%
2022-09-30 $45.03B $25.72B 57.11%
2022-06-30 $45.55B $26.44B 58.05%
2022-03-31 $44.51B $25.39B 57.04%
2021-12-31 $43.08B $24.54B 56.97%
2021-09-30 $42.31B $24.04B 56.83%
2021-06-30 $40.23B $22.43B 55.74%
2021-03-31 $37.34B $21.22B 56.82%
2020-12-31 $34.61B $19.61B 56.65%
2020-09-30 $32.22B $18.28B 56.72%
2020-06-30 $31.44B $18.11B 57.59%
2020-03-31 $32.10B $18.74B 58.40%
2019-12-31 $31.90B $18.67B 58.53%
2019-09-30 $31.36B $18.37B 58.58%
2019-06-30 $30.94B $18.14B 58.64%
2019-03-31 $30.72B $17.92B 58.34%
2018-12-31 $30.58B $17.87B 58.45%
2018-09-30 $30.40B $17.61B 57.91%
2018-06-30 $29.58B $17.07B 57.71%
2018-03-31 $28.45B $16.03B 56.36%
2017-12-31 $27.39B $14.98B 54.70%
2017-09-30 $25.13B $13.63B 54.21%
2017-06-30 $23.61B $12.69B 53.75%
2017-03-31 $22.30B $12.29B 55.09%
2016-12-31 $20.85B $11.76B 56.39%
2016-09-30 $20.71B $11.79B 56.93%
2016-06-30 $20.56B $11.68B 56.83%
2016-03-31 $20.39B $11.59B 56.82%
2015-12-31 $20.41B $11.66B 57.13%
2015-09-30 $20.57B $11.70B 56.85%
2015-06-30 $20.50B $11.55B 56.32%
2015-03-31 $20.39B $11.36B 55.74%
2014-12-31 $20.25B $11.03B 54.47%
2014-09-30 $18.90B $10.06B 53.21%
2014-06-30 $18.65B $9.87B 52.92%
2014-03-31 $19.03B $10.00B 52.53%
2013-12-31 $19.66B $10.46B 53.23%
2013-09-30 $18.84B $9.92B 52.68%
2013-06-30 $19.28B $10.13B 52.55%
2013-03-31 $19.14B $10.17B 53.13%
2012-12-31 $19.05B $10.15B 53.29%
2012-09-30 $26.24B $15.18B 57.86%
2012-06-30 $30.79B $18.25B 59.27%
2012-03-31 $35.09B $21.05B 59.99%
2011-12-31 $38.85B $23.31B 60.00%
2011-09-30 $38.44B $22.69B 59.03%
2011-06-30 $37.30B $21.78B 58.40%
2011-03-31 $36.51B $21.32B 58.39%
2010-12-31 $35.17B $20.50B 58.30%
2010-09-30 $33.99B $19.58B 57.62%
2010-06-30 $33.08B $19.05B 57.60%
2010-03-31 $31.74B $18.14B 57.13%
2009-12-31 $30.76B $17.56B 57.06%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $235.957B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $147.560B 37.59
Stryker (SYK) United States $144.011B 30.10
EssilorLuxottica (ESLOY) France $128.708B 0.00
Medtronic (MDT) Ireland $111.928B 15.99
Lonza Group Ag (LZAGY) Switzerland $50.371B 0.00
Haleon (HLN) United Kingdom $48.904B 27.49
ResMed (RMD) United States $36.560B 27.72
Agilent Technologies (A) United States $33.258B 22.04
GE HealthCare Technologies (GEHC) United States $33.082B 15.84
Terumo (TRUMY) Japan $26.680B 34.37
Insulet (PODD) United States $21.438B 84.69
Koninklijke Philips (PHG) Netherlands $21.384B 15.43
Zimmer Biomet Holdings (ZBH) United States $18.060B 11.71
Baxter (BAX) United States $15.713B 11.81
Smith & Nephew SNATS (SNN) United Kingdom $12.872B 0.00
Demant (WILYY) Denmark $9.377B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Bio-Rad Laboratories (BIO) United States $6.175B 21.94
Lantheus Holdings (LNTH) United States $5.385B 13.58
Prestige Consumer Healthcare (PBH) United States $4.149B 18.47
Perrigo (PRGO) Ireland $3.664B 9.30
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.367B 15.31
ICU Medical (ICUI) United States $3.250B 24.18
Envista Holdings (NVST) United States $3.127B 26.73
GN Store Nord (GNNDY) Denmark $2.263B 19.32
QuidelOrtho (QDEL) United States $1.954B 13.59
LeMaitre Vascular (LMAT) United States $1.833B 41.46
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.357B 0.00
Neogen (NEOG) United States $1.200B 15.67
AdaptHealth (AHCO) United States $1.161B 11.81
Green Thumb Industries (GTBIF) United States $1.048B 23.71
BioLife Solutions (BLFS) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.970B 12.80
Kestra Medical Technologies (KMTS) United States $0.904B 0.00
InMode (INMD) Israel $0.844B 8.55
Evolus (EOLS) United States $0.640B 0.00
CeriBell (CBLL) United States $0.624B 0.00
Owens & Minor (OMI) United States $0.602B 5.08
Maravai LifeSciences Holdings (MRVI) United States $0.542B 0.00
Capricor Therapeutics (CAPR) United States $0.538B 0.00
Curaleaf Holdings (CURLF) Canada $0.524B 0.00
Valneva SE (VALN) France $0.510B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.407B 0.00
SNDL (SNDL) Canada $0.339B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.53
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Aurora Cannabis (ACB) Canada $0.329B 61.50
Canopy Growth (CGC) Canada $0.272B 0.00
Viemed Healthcare (VMD) United States $0.263B 22.50
Sanara MedTech (SMTI) United States $0.256B 0.00
Sanuwave Health (SNWV) United States $0.254B 0.00
ZimVie (ZIMV) United States $0.253B 11.63
Cerus (CERS) United States $0.252B 0.00
Cresco Labs (CRLBF) United States $0.245B 0.00
Quanterix (QTRX) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Biote (BTMD) United States $0.207B 6.12
Brainsway (BWAY) Israel $0.206B 55.30
Omeros (OMER) United States $0.199B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Organigram Global (OGI) Canada $0.187B 0.00
High Tide (HITI) Canada $0.185B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.57
Verano Holdings (VRNOF) United States $0.174B 0.00
Exagen (XGN) United States $0.152B 0.00
Vireo Growth (VREOF) United States $0.140B 0.00
FitLife Brands (FTLF) United States $0.131B 15.33
Jin Medical (ZJYL) China $0.107B 0.00
MacroGenics (MGNX) United States $0.096B 0.00
Fonar (FONR) United States $0.090B 11.37
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Agape ATP (ATPC) $0.084B 0.00
TerrAscend (TSNDF) Canada $0.075B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Nephros (NEPH) United States $0.041B 48.64
United-Guardian (UG) United States $0.037B 13.19
Rockwell Medical (RMTI) United States $0.032B 0.00
Cellectar Biosciences (CLRB) United States $0.019B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
INLIF (INLF) $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00